SUZANO/WOODSPIN
10.5.2024 11:01:28 CEST | Business Wire | Press release
Woodspin, the exclusive producer and distributor of wood-based SPINNOVA® fibre, has obtained Forest Stewardship Council® (FSC) Chain of Custody certification. This recognizes that wood used by Woodspin for its manufacturing can be fully traced from its origin to the final fibre product, providing its customers with the assurance of sustainable sourcing.
Woodspin is a 50/50 joint venture between Suzano, the world’s largest hardwood pulp producer, and Spinnova, an innovative Finnish materials technology company. Woodspin uses responsibly grown eucalyptus hardwood planted, harvested, and sourced by Suzano on farms in Brazil. Suzano is the world’s largest eucalyptus grower and manages 26,000 km2 of land, of which 40 percent is set aside for permanent conservation.
FSC® is renowned as the most rigorous international standard for responsible forestry. FSC® certification ensures that a forest is being managed in a way that preserves biological diversity and benefits the lives of local people and workers while ensuring it sustains economic viability.
Woodspin produces the unique, wood-based SPINNOVA® fibre without harmful chemicals or pollution. SPINNOVA® fibre has a 74 percent smaller life cycle carbon footprint and 98 percent less water consumption than conventional cotton.* The exclusive use of Suzano’s eucalyptus-based raw materials enables Woodspin to guarantee end-to-end traceability while remaining committed to zero deforestation and upholding comprehensive ethical and sustainable practices.
Jari Aittakari, Sales Director at Woodspin, said:
“Consumers and stakeholders at every stage of the textiles value chain deserve to know the origin of the products they buy, that these have been ethically produced, and that the materials used to make them have been sustainably sourced.
We recognize that the demand for supply chain transparency is increasing. This FSC® certification demonstrates to our partners – be that brands or producers – that Woodspin’s SPINNOVA® fibre is produced to the highest standard, from farm to fibre, without compromise.”
Fabian Farkas, Chief Markets Officer at FSC® International, said:
“As the forestry sector continues to push boundaries through innovation, key players are increasingly recognizing FSC® as the solution provider for responsible sourcing. Woodspin's FSC® Chain of Custody certification is such a significant milestone, paving the way for a more sustainable and scalable textile fibre production and ultimately a fossil fuel-free world.”
This certification follows the 2023 opening of Woodspin’s first facility producing wood-based SPINNOVA® fibre in Jyväskylä, Finland. This plant produces biodegradable textile fibres, enabling garments with hand feel close to the natural fibres made responsively from trees. Woodspin’s modern facility uses Spinnova’s fibre technology, which is designed to produce zero waste. It uses an advanced energy recovery system to recycle its only by-product – surplus heat – which can be reused in a local heating network.
The wood-based SPINNOVA® fibre is already being used by global fashion brands such as adidas and Bestseller.
About Woodspin
Woodspin is the exclusive producer and seller of wood-based SPINNOVA® fibre, a sustainable, recyclable, material made from trees. Woodspin is a 50/50 joint venture between the world’s largest hardwood pulp producer, Suzano, and Spinnova, an innovative Finnish materials technology company. Woodspin’s unique product fuses the responsibly-grown eucalyptus hardwood of Suzano with the pioneering technology of Spinnova. In our process we use radically less water and fewer CO2 emissions than alternative fibres, requiring no harmful chemicals, and leaving no waste by-products. http://woodspin.com/
About FSC ®
FSC® is a non-profit organization that provides a proven sustainable forest management solution. Currently, over 150 million hectares of forest worldwide is certified according to FSC® standards. It is widely regarded as the most rigorous forest certification system among NGOs, consumers, and businesses alike to tackle today’s deforestation, climate, and biodiversity challenges. The FSC® forest management standard is based on ten core principles designed to address a broad range of environmental, social and economic factors. FSC’s “check tree” label is found on millions of forest-based products and verifies that they are sustainably sourced, from forest to consumer. www.fsc.org.
About SPINNOVA – Sustainable textile materials, naturally
Spinnova transforms the way textiles are manufactured globally. Based in Finland, Spinnova has developed breakthrough patented technology for making textile fibre out of wood or waste, such as leather, textile or agricultural waste, without harmful chemicals. The SPINNOVA® fibre creates zero waste, and its CO2 emissions and water consumption are minimal. SPINNOVA® fibre is biodegradable and recyclable.
Spinnova is committed to using only sustainable raw materials such as FSC certified wood and waste. SPINNOVA® fibre is produced without harmful or complex chemical processes, and has the touch and feel of natural fibres such as cotton and linen. Spinnova has received awards from Fast Company, ISPO, Scandinavian Outdoor, ANDAM, Monocle and Marie Claire UK.
Spinnova’s shares (SPINN) are listed on the Nasdaq First North Growth Market Finland.
SPINNOVA® home: www.spinnova.com
Corporate & IR site: www.spinnovagroup.com
About Suzano
Suzano is the world’s largest producer of market pulp. Our responsibly grown raw materials are used in products reaching over two billion people in more than 100 countries, including tissue and toilet paper, books, printing and writing paper, diapers and period products, packaging, textiles, and a range of innovative applications that can replace products made from fossil fuels.
Our pulp is made using biomass produced from farmed eucalyptus trees, offering a biodegradable, renewable and recyclable raw material for consumer and industrial use. We plant 1.2 million trees a day and only harvest what we plant. We manage around 26,000 km2 of land and around 40% of this is protected for permanent conservation, with a zero deforestation policy across all of our operations.
Suzano’s history goes back over 100 years. We are listed on the B3 stock exchange in Brazil (SUZB3) and the NYSE (SUZ) in the United States. Learn more at: www.suzano.com.br/en.
Disclaimer
*CO2e emission comparison is based on a projected product carbon footprint conducted by a third-party expert following the ISO 14067:2018 standard. Ecoinvent database has been used as the source for global average CO2e emissions of conventional cotton. Water consumption comparison is based on a projected, screening Life Cycle Assessment (LCA) conducted by a third-party expert. Both comparisons include raw material supply, transportation of raw materials, and manufacturing of the product (cradle-to-gate).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240510834910/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
